gut microbiota and atherosclerosis: role of b cell for atherosclerosis focusing on the gut-immune-b2 cell axis

Atherosclerosis is the leading cause of cardiovascular mortality and morbidity worldwide and is described as a complex disease involving several different cell types and their molecular products. recent studies have revealed that atherosclerosis arises from a systemic inflammatory process, including the accumulation and activities of various immune cells. however, the immune system is a complicated network made up of many cell types, hundreds of bioactive cytokines, and millions of different antigens, making it challenging to readily define the associated mechanism of atherosclerosis. nevertheless, we previously reported a potential persistent inflammatory process underlying atherosclerosis development, centered on a pathological humoral immune response between commensal microbes and activated subpopulations of substantial b cells in the vicinity of the arterial adventitia. accumulating evidence has indicated the importance of gut microbiota in atherosclerosis development. commensal microbiota are considered important regulators of immunity and metabolism and also to be possible antigenic sources for atherosclerosis development. however, the interplay between gut microbiota and metabolism with regard to the modulation of atherosclerosis-associated immune responses remains poorly understood. here, we review the mechanisms by which the gut microbiota influence atherogenesis, with particular focus on humoral immunity and b cells, especially the gut-immune-b2 cell axis.